Biogen Idec (NQ: BIIB )
194.12
-1.69
(-0.86%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 24, 2024
Add to My Watchlist
Press Releases about Biogen Idec
Biogen to Realign Resources for Alzheimer's Disease Franchise
January 31, 2024
From Biogen Inc.
Via GlobeNewswire
From Biogen Inc.
Via GlobeNewswire
FDA Approves Biogen’s TOFIDENCE™ (tocilizumab-bavi), a Biosimilar Referencing ACTEMRA®
September 29, 2023
From Biogen Inc.
Via GlobeNewswire
Biogen Completes Acquisition of Reata Pharmaceuticals
September 26, 2023
From Biogen Inc.
Via GlobeNewswire
Are Gene Therapy Stocks The Market's Next Big Winners?
September 25, 2023
Via MarketBeat
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Biogen Appoints Jane Grogan as Head of Research
September 06, 2023
From Biogen Inc.
Via GlobeNewswire
From Brodsky & Smith LLC
Via GlobeNewswire
From Brodsky & Smith LLC
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.